Nyxoah SA
NYXH NasdaqΒ· Surgical & Medical Instruments & Apparatus
Last close Β· Oct 26, 2026
$0.86
KIRA Β· Stoqlyβs AI analyst, in plain words
- Nyxoah SA lost $102M in fiscal 2025.
- Free cash flow was β$78.7M in fiscal 2025, β of revenue.
Market cap
$32.6M
P/E
β
Revenue
β
Net income
β$102M
Free cash flow
β$78.7M
Operating margin
β
Nyxoah SA in 30 seconds Β· fiscal 2025
Does it make a profit?
β$102M
No. It lost money last year.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Nyxoah SA does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F Β· Mar 26, 2026
- Legal name
- Nyxoah SA
- CIK
- 0001857190
Nyxoah SA Β· NYXH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | β$32.7M | β$32.8M | β$46.7M | β$64.1M | β$102M |
| Diluted EPS | β$1.37 | β$1.27 | β$1.67 | β$1.96 | β$2.67 |
| Cash | |||||
| Cash from operations | β$30.0M | β$30.2M | β$48.4M | β$53.3M | β$77.8M |
| Capital expenditure | $1.7M | $0.9M | $2.7M | $1.3M | $0.9M |
| Free cash flow | β$31.7M | β$31.2M | β$51.1M | β$54.5M | β$78.7M |
| Share count change | 31.5% | 8.5% | 8.3% | 17.1% | 16.4% |
| Debt and strength | |||||
| Cash and short-term investments | $153M | $19.1M | $23.9M | $35.5M | $35.3M |
| Shareholders' equity | $168M | $128M | $108M | $118M | $57.7M |
| Current ratio | 12.1x | 6.7x | 4.7x | 4.6x | 1.3x |
| Interest coverage | β12.7x | β7.5x | β12.1x | β11.6x | β7.2x |
| Returns and quality | |||||
| Return on equity | β19.4% | β22.1% | β39.5% | β56.7% | β115.8% |
| Return on tangible equity | β23.4% | β38.3% | β82.3% | β98.1% | β |
| Altman Z'' | 9.2 | 4.6 | 0.2 | β1.3 | β11.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nyxoah SA Β· NYXH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.86 a share, the company is worth $32.6M.
Source: SEC EDGAR XBRL filings (CIK 0001857190). Data updated October 24, 2026. Filed in EUR under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only β not investment advice. Check the original filings before relying on any figure.
